Molecular Biology and Tumor Evolution
ACC molecular biology is easier to synthesize when IGF-driven growth biology, Wnt and TP53-related tumor suppression failure, epigenetic and transcriptomic subclassification, and metastatic evolution are read as related but distinct layers.123
Research Map
IGF and Growth Programs in ACC
These papers focus on IGF2 overexpression, adrenal growth signaling, and the developmental programs that first framed ACC as a targetable disease.123
Grouped note: IGF and Growth Programs in ACC
Wnt, TP53, and Cell-Cycle Dysregulation in ACC
This cluster follows beta-catenin, TP53, RB, chromosomal instability, and related mechanisms that define aggressive cortical malignancy.123
Grouped note: Wnt, TP53, and Cell-Cycle Dysregulation in ACC
Epigenetic and Transcriptomic Subtypes in ACC
These studies define methylation groups, miRNA programs, and transcriptomic classes that stratify prognosis beyond stage alone.123
Grouped note: Epigenetic and Transcriptomic Subtypes in ACC
Tumor Evolution, Microenvironment, and Metastatic Plasticity in ACC
This note groups the literature on clonal evolution, immune contexture, tumor microenvironment, and the biology of recurrence or metastasis.123
Grouped note: Tumor Evolution, Microenvironment, and Metastatic Plasticity in ACC
How to Read This Literature
The grouped notes below separate foundational pathways from newer subtype and evolution work that may matter more for biomarker-guided care.123
See Also
References
Footnotes
-
Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase.. J Clin Invest. 1977. PMID: 13086. Local full text: 13086.md ↩ ↩2 ↩3 ↩4 ↩5 ↩6
-
Metabolic regulation of steroidogenesis in isolated adrenocortical carcinoma cells. ACTH regulation of guanosine cyclic 3’ :5’ - monophosphate levels.. Biochem Biophys Res Commun. 1977. PMID: 20888. Local full text: 20888.md ↩ ↩2 ↩3 ↩4 ↩5 ↩6
-
ACTH and prostaglandin receptors in human adrenocortical tumors. Apparent modification of a specific component of the ACTH-binding site.. J Clin Invest. 1975. PMID: 169292. Local full text: 169292.md ↩ ↩2 ↩3 ↩4 ↩5 ↩6